SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-054267
Filing Date
2021-11-04
Accepted
2021-11-04 08:30:25
Documents
12
Period of Report
2021-11-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K scyx-8k_20211101.htm   iXBRL 8-K 41361
  Complete submission text file 0001564590-21-054267.txt   170339

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA scyx-20211101.xsd EX-101.SCH 5776
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE scyx-20211101_lab.xml EX-101.LAB 19480
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE scyx-20211101_pre.xml EX-101.PRE 11632
5 EXTRACTED XBRL INSTANCE DOCUMENT scyx-8k_20211101_htm.xml XML 3544
Mailing Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548
Business Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548 201-884-5485
SCYNEXIS INC (Filer) CIK: 0001178253 (see all company filings)

IRS No.: 562181648 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36365 | Film No.: 211378181
SIC: 2834 Pharmaceutical Preparations